Investment Analysts’ updated eps estimates for Tuesday, May 31st: National Bank Financial assumed coverage on shares of CCL Industries (OTCMKTS:CCDBF). The firm issued an outperform rating on the stock. Intercorp Financial Services (NYSE:IFS) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Intercorp Financial Services […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Rating) was the recipient of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 61,500 shares, a drop of 16.7% from the April 30th total of 73,800 shares. Based on an average trading volume of 11,300 shares, the […]
Investment Analysts’ upgrades for Tuesday, May 10th: ADTRAN (NASDAQ:ADTN) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $20.00 price target on the stock. According to Zacks, “ADTRAN reported relatively healthy first-quarter 2022 results, wherein both the bottom and the top lines beat the […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) released its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.01), MarketWatch Earnings reports. LBPH traded up $0.12 during trading on Friday, reaching $4.74. 1,346 shares of the company traded hands, compared to its average volume of […]
Longboard Pharmaceuticals (NASDAQ:LBPH – Get Rating) and Kiniksa Pharmaceuticals (NASDAQ:KNSA – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Insider and Institutional Ownership 62.3% of Longboard Pharmaceuticals shares […]